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A. Introduction 
 
The experiments that constitute the results of the present thesis were held out at 
the Department of Toxicology (Faculty of Pharmacy, University of Cagliari, Italy) 
under the supervision of Professor Gaetano Di Chiara and with the scientific 
collaboration of Dr. Maria Antonietta De Luca.  
As indicated in the title, the thesis discusses the role of the medial prefrontal 
cortex (mPFC) dopamine (DA) in the nucleus accumbens (NAc) neurochemical and 
behavioral responses to taste stimuli. Nucleus Accumbens DA has been implicated in 
reward and motivational processes while disturbances in DAergic transmission in the 
mPFC have been involved in several disorders such as schizophrenia and depression. 
In particular, an hypodopaminergic state in the mPFC has been proposed to mediate 
the negative symptoms of schizophrenia. Furthermore, disturbances in cognitive 
functions related to mPFC DA neurotransmission have been reported to occur in 
substance abuse and in compulsive disorders in general.  
Studying the responsiveness of mesolimbic DA after lesions of mPFC DAergic 
input can provide important information on the nature of the interaction between 
these DAergic systems and help understanding the functional organization in the 
circuits studied. Furthermore, it might shed light on aspects of behavior that are 
often neglected, such as disturbances in motivational learning. These studies can in 
turn lead to a better understanding of the mechanism of action of current 
medications of schizophrenia and depression and to develop new therapeutic 
strategies for these conditions. 
 
 
A.1 Dopamine and Dopaminergic Systems 
 
Dopamine is a biogenic amine that derives from the aminoacid tyrosine (see 
figure A.1) and a neurotransmitter that acts through G-protein-coupled receptors 
(GPCRs) named D1 to D5 according to their coupling with specific G proteins and their 
ability to stimulate or inhibit adenylyl cyclase (AdC): D1-like family of receptors 
A.Introduction 
 
 
2 
 
(which includes D1 & D5 receptors) that stimulate the synthesis of AdC and D2-like 
family (D2, D3 & D4 receptors) that inhibit it (Webster, 2001). 
 
 
Figure A.1 The biosynthetic pathway of DA (source: Kolb & Whishaw, 2003) 
 
There have been identified three groups of anatomically and functionally different 
subgroups of DA midbrain neurons that give rise to the three out of four major 
DAergic systems of the mammalian brain (Carlsson et al., 1962; Dahlström & Fuxe, 
1964). The nigrostriatal or mesostriatal pathway rises from the cell bodies of the 
neurons of the substantia nigra pars compacta (SNc, lateral A9 group) which project 
primary to the dorsal striatum. This pathway has prominent role in the control of 
voluntary movement and is also related to the initiation and execution of habitual 
behavior, while its selective degeneration is responsible for the motor symptoms 
observed in patients with Parkinson’s disease. The cell bodies of the mesolimbic and 
the mesocortical systems are located in the ventral tegmental area (VTA – medial 
A10 group & retrorubal field – A8 group, respectively) and project to the limbic 
system (NAc, central nucleus of amygdala and septum, entorhinal cortex, olfactory 
tubercules) and the medial prefrontal cortex (mPFC) respectively. These pathways 
are involved in regulation of cognition, emotions and reward (see below) and have 
been implicated in pathological conditions as drug addiction, depression and 
schizophrenia. The tuberoinfundibular system consists of DAergic neurons located in 
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the wall of the third ventricle (A12 & A14 cell groups), within the arcuate nucleus of 
the hypothalamus, that project to the median eminence and are involved in 
endocrine control. There, DA acts as a prolactin release inhibiting factor in the 
hypophysial portal circulation. Dopaminergic projections are also sent from the 
dorsal hypothalamus (A11 & A13 groups) to the spinal cord and neurons containing 
DA can also be found in the olfactory system (A15 cells in the olfactory tubercule and 
A16 in the olfactory bulb) and in the retina (A17 group of cells) (DeLong, 2000; 
Kandel, 2000; Saper, 2000; Schwartz, 2000; Dianne et al., 2008) (see figure A.2).  
Dopamine transmission takes place in two independent but interactive releasing 
modes with distinct temporal properties: a fast, transient, “phasic” release 
dependent on action potentials and a constant, “tonic”, action potential-
independent release. Tonic DA is released slowly with a prolonged onset and the 
whole process takes long periods of time - from minutes to hours. This kind of 
release is regulated by presynaptic glutamatergic afferents that synapse with the 
DAergic terminals and underlies the basal levels of DA in subcortical areas. On the 
other hand, phasic DA release is triggered by behaviorally relevant stimuli (Grace, 
1991, 2000; Gonon, 1997; Dreher & Burnod, 2002).  
The aim of the studies presented in the current thesis was to investigate the role 
of the distinct DAergic systems in reward processes and the interaction between 
these systems. Despite the fact that the nigrostriatal pathway, apart from its role on 
the coordination of movement, has also been demonstrated to participate in some 
forms or aspects of reward functions (Young et al., 1992; Ito et al., 2002), the 
studies of the present thesis focused on more traditionally “reward circuits” i.e. the 
mesolimbic and mesocortical DAergic systems and in particular the projections from 
VTA to the mPFC and to the NAc. Below, there will be presented briefly some 
anatomical information and theories regarding the role of DA in these areas and 
after these information there will be discussed findings from the literature 
suggesting interaction between cortical and subcortical DA. At the end of the 
chapter will be presented the aim of the study. 
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Figure A.2 Dopaminergic pathways in the rat brain (from Schwartz, 2000) 
 
 
A.2 Nucleus Accumbens 
 
A.2.1 Introduction 
 
Nucleus Accumbens is a small nucleus ventral to the head of the caudate nucleus 
(see figures A.2, A.3, B.6) and together with the ventromedial part of the caudate-
putamen and the olfactory tubercules comprise the anatomical complex often 
referred as “ventral striatum” (Nakano, 2000). Nucleus Accumbens is described as an 
“integral, but specialized part of the striatal complex” (Heimer e al., 1991) and 
consists mainly (90-95%) of medium spiny neurons; on the spines and the bodies of 
them synapse afferent fibers from interneurons, the cortex and other areas (see 
below) (Somogyi et al., 1979; Freund et al., 1984; Smith & Bolam, 1990). 
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Figure A.3 Position of the Nucleus Accumbens (NAc) in the human brain (from library.thinkquest.org) 
 
For long time since its first description, NAc was considered as a modified 
appendage of the striatum, rather than a discrete nuclear entity (Zahm & Brog, 
1992). It was in the middle ‘80s when the studies of Groenewegen & Russchen 
(1984) and Zaborszky et al. (1985) demonstrated significant differences between the 
projections of the lateral and the medial NAc and introduced the division of the NAc 
into two histochemically distinct compartments: the “core” and the “shell”.  
Further anatomical (Heimer et al., 1991; Zahm & Brog, 1992; Zahm & Heimer, 
1993), histochemical (Jongen-Relo et al., 1993; Jongen-Relo et al., 1994), behavioral 
(Deutch & Cameron, 1992; Prinssen et al., 1994, Pierce & Kalivas, 1995; Corbit & 
Balleine, 2011) and neurochemical (Pontieri et al., 1995, 1996; Tanda et al., 1997; 
Bassareo et al., 2002) studies established scientifically the division of NAc in these 
two compartments, the ventro-medial “shell” and dorsolateral “core” which have 
distinct structure, properties and physiological roles. Core is considered as part of 
the nigrostriatal DAergic pathway and is involved mostly in motor behavior while the 
shell comprises part of the mesolimbic dopaminergic pathway and mesolimbic 
system and is involved in reward processes, emotions and cognitive functions 
(Alexander & Crutcher, 1990; Alheid et al., 1990, Smith & Bolam, 1990; Deutch & 
Cameron, 1992). Histological, biochemical and connectional methods have shown 
that the NAc shell is characterized by typical striatal features but also by 
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characteristics of those of the extended amygdala, suggesting that the NAc shell 
comprises a transitional or integrative zone between the two areas (Heimer et al., 
1991).  
As mentioned above (see section A.1), NAc is the main target of the mesolimbic 
dopaminergic system - it receives dense DAergic innervation from the VTA. It also 
receives inputs from a lot of cortical and non cortical areas, including the 
hippocampal formation, the mPFC, the insular cortex, the amygdala and the 
thalamus and is characterized as a “portal” of prefrontal inputs to the striatum 
(Nakano, 2000). The most prominent projections of the NAc reach the pallidum, the 
substantia nigra and the VTA (Swanson & Cowan, 1975; Williams et al., 1977; Nauta 
et al., 1978).  
The two distinct compartments of the nucleus receive afferents from and project 
to different areas of the brain. Tract-tracing methods have shown that both shell and 
core areas project to pallidal, hypothalamic and mesencephalic areas but core 
projections arrive more prominently to the substantia nigra while those of the shell 
to the VTA. In addition, shell projects also to the extended amygdala unlike core 
(Heimer et al., 1991).  
Several neuroactive/neuromodulatory substances have been detected in the NAc 
as acetylcholine (Ach), DA, serotonin (5-HT), noradrenaline (NA), somatostatin 
(SOM), gamma-aminobutyric acid (GABA), substance P (SP), glutamate (Glu), 
neurotensin, Leu-enkephalin, Met-enkephalin, cholecystokinin (CCK), melatonin, 
histamine, galanine and neuropeptide Y (Voorn et al., 1989; Alheid et al., 1990; 
Graybiel, 1990; Selden et al., 1994, Parent et al., 1995). 
Nucleus Accumbens is suggested to be an interface between limbic and motor 
functions (Mogenson et al., 1980; Mogenson & Yang, 1991) and to be involved in 
several aspects of behavior as motivation, reward, water and food intake, sexual 
behavior, emotions and cognitive functions and to play a major role on drug 
dependence (Wise, 1987; Alexander & Crutcher, 1990; Alheid et al., 1990, Smith & 
Bolam, 1990, Di Chiara, 2002; Di Chiara et al., 2004; Di Chiara & Bassareo, 2007; 
Anselme, 2009). It has been suggested that the shell of the NAc has more limbic 
functions (more specific role in emotion and motivation) while the core 
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compartment is involved mainly in the motor expression of motivated behaviors 
(Zahm & Brog, 1992; Bassareo & Di Chiara, 1999; Brauer et al., 2000). 
 
 
A.2.2 The Role of Dopamine in the Nucleus Accumbens 
 
The role of DA in general and in the mesolimbic system in particular has been a 
subject of debate for almost 30 years. Nowadays it is generally accepted that the 
mesolimbic DAergic system plays a critical role in conventional and drug reward, 
motivation and reinforcement, but the exact nature of this role is still unclear. 
One of the first studies to link DA to motivation by conventional rewards was 
made by Ungerstedt (1971) who showed that lesion of the nigrostriatal DA system by 
6-hydroxydopamine (6-OHDA) induced severe aphagia and adipsia in rats. Further 
experiments with DA receptor antagonists led to the “anhedonia hypothesis” that 
viewed DA as the substrate of the hedonic/pleasant effects of all rewards - from 
drugs of abuse to natural stimuli as sex and food (Yokel & Wise, 1975; Wise, 1980, 
1982). This theory remained influential for a long time among scientists and among 
the media and public opinion as well. Koob and Le Moal (1997, 2001), influenced by 
Wise’s and others contemporary theories of DA role in reward, speculated that drug 
exposure changes the “reward set point” of the organism so that withdrawal in 
depended individuals results in reduced DAergic transmission and in a state of 
anhedonia.  
However, the “anhedonia hypothesis” was thought to be unable to explain the 
observation that pharmacological blockade of DA receptors does not suppress 
hedonic responses estimated by the taste reactivity paradigm (see next chapter, 
section B.6.1) (Peciña et al. 1997; Berridge & Robinson, 1998; Di Chiara et al., 2004). 
Thus, food reward has been found to be independent of DA transmission (Salamone 
et al., 1997; Berridge & Robinson, 1998) and DA is also released by aversive events 
and stress (McCullough & Salamone, 1992; Salamone, 1994; Kalivas & Duffy, 1995). 
Microdialysis and in vivo voltammetry studies have shown that DA transmission can 
be activated in anticipation of the consumption of drug or food rewards or by 
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presentation of reward-conditioned stimuli (Blackburn et al., 1989; Phillips et al., 
1993; Bassareo et al., 2007). In line with these studies are the observations of 
Schultz and his colleagues (see below) that DA neurons fire in response to the 
presentation of stimuli conditioned to rewards.  
Further studies on the properties of DAergic transmission showed that the role of 
DA in reward is not simply that of mediating pleasure elicited by a rewarding 
stimulus. Due to the spatial and temporal characteristics of its release and diffusion 
in the extracellular space, localization and transduction mechanisms of its receptors 
(extrasynaptic release and transduction by GPCR), DA exerts a delayed, tonic 
influence, acting “in parallel” with stimuli that follow its release, “modulating their 
ability to elicit a response”, rather than “in series” with them (Di Chiara & Bassareo, 
2007).  
Berridge and his colleagues proposed a theory, in which DA has a role different 
from that of mediating the hedonic properties of rewards. This role is that of 
attributing incentive salience to conditioned stimuli. They distinguish two  
components of rewarding stimuli: “liking”, the unconscious hedonic evaluation of a 
stimulus, and “wanting”, “the underlying core process that instigates goal-directed 
behavior, attraction to the stimulus, and consumption of the goal object” (Berridge & 
Robinson, 1998 pp 313). According to this theory, DA participates in “wanting” and 
not in ''liking'' (Berridge et al., 1989; Robinson & Berridge, 1993; Berridge, 1996; 
Berridge & Robinson, 1998).   
However, it has been argued (Di Chiara, 2002) that, although DA is not the 
substrate of the hedonia associated to food consumption, it is nonetheless the 
substrate of the appetitive properties of food-conditioned incentive stimuli acting 
during the preparatory phase of feeding behavior. This kind of hedonia, 
characterized by euphoria and behavioral arousal (“incentive arousal”, Di Chiara, 
2002) is mimicked by cocaine and amphetamine psychostimulants and is thought to 
be related to stimulation of DA transmission in the NAc shell (Di Chiara, 2002). On 
this basis, two kinds of hedonia have been distinguished, a DA-independent 
consummatory or stimulus-bound hedonia, such as that associated to food taste, 
and a DA-dependent preparatory or state-hedonia, associated to the incentive 
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arousal state of food search and approach. These two kinds of hedonia correspond 
to distinct phases of motivated behavior, appetitive/preparatory and, respectively, 
consummatory, elicited by distinct stimuli, distal (visual, acoustic, olfactory) and, 
respectively, proximal (tactile, proprioceptive, taste) and associated to distinct 
behavioral response patterns of search, exploration and approach independent from 
the specific reward (appetitive behavior) and, respectively, reward specific motor 
responses (consummatory responses). 
Furthurmore, according to Salamone and colleagues “wanting” can be 
distinguished into two separate components, “directional” and “activational”, where 
directional aspects can be appetitive in nature and activational aspects include “the 
initiation and sustaining of instrumental actions or the tendency to work for food”; 
“the tendency to work for motivational stimulus, and overcome response constraints” 
(Salamone & Correa, 2002 pp 1 & 15). According to these authors, DA in the NAc is 
involved in instrumental action in tasks with a high degree of “work-related response 
costs” (Salamone et al., 2001; Salamone & Correa, 2002). 
A popular theory of the role of DA is the “prediction error hypothesis” of Schultz 
and colleagues. This theory is based on correlative evidence arising from 
extracellular recording of putative DA neurons in the monkey VTA. These studies 
showed that food and liquid rewards elicit phasic firing in most midbrain DA 
neurons. These neurons are activated by the unpredicted occurrence of reward or of 
stimuli conditioned to it. Presentation of stimuli conditioned to food reward 
prevents the activation of DA units by food itself. Thus, a fully predicted reward 
doesn’t elicit a response. On the other hand, omission of a predicted reward induces 
depression of DA neurons. Therefore, according to the “reward-prediction error” 
hypothesis, DA codes for the occurrence of an unpredicted reward and for the 
omission of a predicted one (Schultz et al., 1993; Schultz et al., 1997; Schultz, 2007). 
Although this hypothesis can account for the phasic activity of DA neurons in 
response to rewards and their conditioned stimuli, it does not necessarily applies to 
the action of DA on its receptive neurons. In fact, the temporal and spatial properties 
of DA mediated signals are quite different from those of a fast transmitter acting via 
ionotropic receptors (Di Chiara & Bassareo, 2007). Thus, by the time DA is released, 
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diffuses in the extracellular space, reaches its receptors and activates them, the 
phasic response of DA neurons is transformed into a tonic influence on a widely 
distributed range of DA sensitive neural elements. Thus, the computational 
properties that are attributed to DA by Schultz theory do not fit with those of a 
neuromodulator like DA but rather with those of a fast, ionotropic excitatory 
transmitter acting like glutamate. As a matter of fact, evidence is now being 
provided that glutamate is a co-transmitter of DA in mesolimbic neurons (Lavin et 
al., 2005). According to Schultz and colleagues, DA, released as a result of an error in 
the prediction of reward, acts as a teaching signal in associative and hebbian learning 
functions. However, the evidence provided in support of this theory is only 
circumstantial. 
Unfamiliar palatable food stimulates DA release in the shell and core and in the 
mPFC but only in the NAc shell this effect undergoes habituation following repeated 
exposure. This property has been related to a role of DA in associative learning 
mediated by food reward. Accordingly, DA release in the NAc shell by food taste 
would serve to consolidate the memory trace of taste stimulus, thus allowing 
association with its post-ingestive consequences, as in a taste aversion paradigm 
(Fenu et al., 2001; Di Chiara & Bassareo, 2007). These and other observations are 
the basis of the view that DA is involved in the acquisition of incentive-motivational 
properties by stimuli conditioned to rewards (incentive learning). The DA subsystem 
specifically involved in this process is NAc shell DA (Di Chiara et al., 2004; Di Chiara 
& Bassareo, 2007). The influence of NAc shell DA on incentive learning is retrograde, 
affecting the association of stimuli that precede or are coincident with reward. Drugs 
of abuse increase DA preferentially in the NAc shell and this effect is thought to 
facilitate the association between drug reward and stimuli that predict their 
occurrence. Since DA is preferentially released in the NAc shell in response to drug-
reward, drug-conditioned stimuli should also release DA in the same area. This is 
indeed what has been found with brain microdialysis after stimuli conditioned to 
drugs of abuse (Bassareo et al., 2007). Food-conditioned stimuli elicit a different 
pattern of DA activation, since they stimulate NAc core but not shell DA (Bassareo et 
al., 2011). Both food- and drug-conditioned stimuli, however, stimulate DA release in 
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the mPFC. Therefore, food-conditioned and drug-conditioned stimuli differentially 
stimulate DA transmission in the NAc shell and core. These differential properties of 
drug- versus food-conditioned stimuli have been assigned an important role in the 
ability of drugs to elicit addiction (Bassareo et al., 2007, 2011). 
Finally, an “anticipatory dynamics model” (and its “uncertainty processing theory 
of motivation” revised form) for the role of DA in motivation and reward has been 
recently proposed. According to this theory, phasic DA release is induced by events 
that comprise “uncertainty with respect to the stimulus arrival”. Dopamine in limbic 
and cortical areas facilitates anticipation which is necessary for the organism to deal 
with uncertainty. Nucleus Accumbens (and the core compartment in particular) is 
the region where signals from other corticolimbic areas regarding anticipation 
converge. Due to its connections with motor areas can fast reduce uncertainty by 
adopting appropriate motor responses to environmental challenges. The theory also 
includes another important role for DA: the facilitation of task related attention 
which serves for motivational specificity (towards a particular reward) to take place. 
This “anticipatory attention” occurs through neuronal pathways co-utilizing DA & 
Ach (Anselme, 2009, 2010). 
 
 
A.3 Prefrontal and Medial Prefrontal Cortex 
 
A.3.1 Introduction 
 
The prefrontal cortex (PFC) consists part of the frontal cortex (FC - along with 
motor and premotor cortices) and is located in the anterior part of it. Originally, 
Jersey Rose and Clinton Woolsey in the late ‘50s, nominated as “prefrontal cortex” 
the area of the frontal lobes of mammals of all species that has strong reciprocal 
projections with the mediodorsal thalamic nucleus (MD) (Groenewegen et al., 1990; 
Kolb & Whishaw, 2003; Steketee, 2003, 2005). Prefrontal cortex is divided in medial 
and lateral parts and more specifically into three main regions: the dorsolateral PFC 
(Broadmann areas 9 & 46), the inferior ventral PFC (areas 11, 12, 13 & 14 – also 
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known as orbitofrontal cortex) and the medial prefrontal (mPFC) cortex which is 
considered part of the anterior cingulate (AC) area (Kolb & Whishaw, 2003) (see 
figure A.4).  
Medial prefrontal cortex is located along the medial wall of the brain hemispheres 
anterior and dorsal to the genu of the corpus callosum (Heidbreder & 
Groenewegen, 2003) and is an area well known to interact through excitatory 
aminoacid (EAA) efferents with subcortical areas (Thierry et al., 1983; Christie et al., 
1985; Sesack et al., 1989; Sesack & Pickel, 1992). It consists of the infralimbic (IL), 
prelimbic (PL - Cingulate gyrus 3 - Cg3 of the anterior cingulate), dorsal and ventral 
anterior cingulate (Cg1 & Cg2) and medial precentral (frontal area 1) cortices from 
ventral to dorsal (van Eden & Uylings, 1985; Groenewegen et al., 1990; van Eden et 
al., 1992; Steketee, 2003, 2005) (see figure A.5).  
 
 
Figure A.4 Schematic representation of the prefrontal cortex (PFC) and its subdivisions in the human 
brain (from focus.psychiatryonline.org) 
 
Medial prefrontal cortex receives the most prominent cortical afferents from the 
contralateral mPFC and the most prominent subcortical afferents from the MD (as 
mentioned above). Both of these afferent connections are glutamatergic in nature. 
Additional glutamatergic input arrives to mPFC from the hippocampus & the 
amygdala (Condé et al., 1990, 1995; Groenewegen et al., 1990; Ray & Price, 1992; 
Kuroda et al., 1993). Furthermore, a source of NA in the mPFC originates from the 
locus coeruleus (LC) and, as already mentioned, of DA from the VTA (Thierry et al., 
1973; Björklund et al., 1978; Foote et al., 1983). Other neuroactive substances as 
GABA (mostly from interneurons), endogenous opioids (there exist mostly δ-
receptors and lower levels of μ- & κ) and cannabinoids (CB1 receptors), 5-HT and 
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neurotensin are also present in the mPFC (Mansour et al., 1994, Moldrich & 
Wenger, 2000; Tzschentke, 2001). As already mentioned above, one of the most 
prominent connections of mPFC is with the MD and a direct feedback loop between 
the two brain regions has been described (Kuroda et al., 1993). Furthermore, it 
provides heavy innervation to subcortical areas as the NAc and the VTA (Thierry et 
al., 1983; Christie et al., 1985; Sesack et al., 1989; Sesack & Pickel, 1992).  
 
 
Figure A.5 The medial prefrontal cortex in the rat brain. Red squares indicate infralimbic (IL), 
prelimbic (PL) and anterior cingulate (Cg1) cortices from ventral to dorsal  
(From Paxinos & Watson, 2007) 
 
Each subarea of the mPFC appears to have distinct afferent and efferent 
connections which might also suggest different functional roles. For instance, the 
subareas of the mPFC show topographical organization regarding their efferents 
where more dorsal parts (anterior cingulate and dorsal prelimbic areas) project to 
the striatum and dorsal parts of the NAc, while the more ventral subareas (ventral 
prelimbic and infralimbic cortices) send fibers to ventral aspects of the NAc, (i.e. 
shell) (Sesack et al., 1989; Berendse et al., 1992). As for the afferents, IL cortex 
receives inputs from the hippocampus and the brain stem (VTA) but not from the 
MD, which makes it, according to some authors, part other than the traditional 
mPFC. As already mentioned, its efferents target principally NAc shell but also the 
rostral MD, the hypothalamus, the amygdala & the brain stem nuclei. Prelimbic 
cortex receives inputs from MD, hippocampus and the VTA. It receives the densest 
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DAergic input among the other mPFC subareas and it also has the strongest 
projection to the VTA. It also projects to the NAc core (as mentioned above), rostral 
MD and basolateral amygdala among other forebrain structures. The anterior 
cingulate subarea receives inputs from the caudal MD thalamus, from other 
neocortical areas and from the VTA.  It projects mainly to the dorsal striatum, the 
caudal MD and to other neocortical and brainstem areas (Thierry et al., 1973; 
Lindvall et al., 1978; Beckstead, 1979; Sesack et al., 1989; Groenewegen et al., 
1990, 1999; Hurley et al., 1991; Berendse et al., 1992; Tzschentke, 2001).   
Being a heterogeneous area, PFC has been reported to be involved in a great 
variety of functions-behaviors, as planning of voluntary movement, adjustment of 
behavior in relation to space, arousal and attention, temporal sequencing of actions, 
planning of forthcoming behavior based on previously acquired information, 
response selection and response inhibition, stress responses, mood, spatial and 
associative learning, memory retrieval and working memory (with a special role of 
DA in the mPFC – see below) (Pinel, 2000; Tzschentke, 2001; Curtis & D’Esposito, 
2003; Kolb & Whishaw, 2003; Ramnani & Owen, 2004; Surmeier, 2007).  
Disturbances in the structure and function of PFC have been reported to exist in 
schizophrenic patients, in individuals with unipolar depression and bipolar disorder. 
It has been suggested that decreased DAergic activity in the mPFC is responsible for 
the negative symptoms that occur in schizophrenia while in depression the reduced 
activity of the area is correlated with the disturbances in memory and attention 
observed in the disorder (Blumberg et al., 1999; Webster, 2001). Regarding 
substance abuse disorders it has been suggested that long term abuse of substances 
might induce changes in important cognitive/executive functions as decision making 
and correct judgment (Powell, 2004). It has also been proposed that dysfunction of 
the PFC (more specifically in the orbitofrontal cortex) due to substance abuse might 
induce inability to achieve control over the use of the substance, incapability to 
cease its intake despite the harmful consequences for the individual (Porrino & 
Lyons, 2000), disturbed ability in comparing the future beneficial effects from the 
cessation and the harmful effects of continuation of the abuse of substance as well 
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as disturbed impulse control and relapse (London et al., 2000; Kalivas & Volkow, 
2005; Garavan & Hester, 2007). 
The mPFC has been implicated in many of the functions mentioned above and is 
generally accepted that participates in “higher order cognitive functions” as 
attentional processes, working memory and behavioral flexibility (Heidbreder & 
Groenewegen, 2003). Some researchers propose a clear distinction between ventral 
and dorsal subdivisions/subareas of the mPFC because of common phylogenetic 
origin but also due to anatomical, neurochemical and functional differences 
observed in the areas. Moreover, lesion, transient or permanent inactivation and 
antagonist-using studies suggest a different role for each subarea of the mPFC. Thus, 
lesions and pharmacological manipulations of the dorsal part of the mPFC (AC and 
dorsal PL cortices) can alter the performance in several tasks. Among others they 
have been shown to increase conditioned fear responses, to impair the acquisition of 
avoidance tasks, to block the expression of cocaine sensitization and to produce 
memory impairments for egocentric responses. On the other hand, lesions of the 
ventral part of the mPFC (ventral PL and IL cortices) have been shown to impair the 
extinction of fear responses; to produce impairments in passive avoidance, working 
memory, shifting to different cue modalities for reinforcement and reversal learning; 
to block conditioned place preference (CPP) to cocaine; and to attenuate the 
development of sensitization to cocaine but not amphetamine. This region seems to 
play a role in the reinstatement of cocaine self administration as its inactivation 
blocks the drug seeking behavior. Furthermore, these lesions impair performance in 
elevated plus maze, taste aversion and behavioral flexibility tests. In conclusion it is 
stated that the dorsal part of the mPFC is mainly involved in temporal sequencing 
regarding behavioral responses and the ventral part in set shifting/behavioral 
flexibility, in guidance of behavior in threatening or aversive conditions and in 
preparatory processes of reacting time performance. For more information 
regarding the functional and anatomical dissociation between the dorsal and ventral 
parts of the mPFC the author suggests the review of Heidbreder & Groenewegen 
(2003). This thesis aims to point out the role of DA in mPFC and not of the whole 
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region (or its subdivisions) per se. Limited information exists for the role of DA in a 
subregion-specific manner and this information will be discussed on the next section.  
 
 
A.3.2 The Role of Dopamine in the Medial Prefrontal Cortex 
 
The DAegic innervation of the mPFC is less dense than this of the NAc or the 
striatum; the basal extracellular and tissue levels of DA are much lower in the mPFC 
(Garris et al., 1993; Ihalainen, 1999; Tzschentke, 2001). The distribution of DA per se 
and of the other elements of the DAergic system as the dopamine transporter (DAT) 
also differs along the ventrodorsal axis of the mPFC. The DAT is more densely 
distributed in the AC than in the PL cortex (Sesack et al., 1998) and DA terminals are 
denser in the PL than the other subregions of the mPFC (Thierry et al., 1973; van 
Eden et al., 1987). 
Dopaminergic terminals from VTA innervate the deep layers of mPFC pyramidal 
cells (Berger et al., 1991; Dreher & Burnod, 2002) and in turn these pyramidal 
neurons send glutamatergic efferents to the VTA (Taber et al., 1995). In addition, DA 
terminals synapse with GABAergic interneurons in the mPFC, modulating their 
function (Penit-Soria et al., 1987; Pirot et al., 1992). Dopamine in the mPFC serves 
as an inhibitory neuromodulator and through the synaptic distribution of the DAergic 
fibers this action can be direct on the pyramidal neurons and/or indirect by 
modulating the GABAergic interneurons’ activity which synapse with the pyramidal 
neurons (Ferron et al., 1984; Godbout et al., 1991; Pirot, 1992; Sesack et al., 1995). 
Thus, it has been shown that, DA or DA agonists administered locally and chemical or 
electrical stimulation of the VTA and the subsequent release of DA in the mPFC 
result in inhibition of the mPFC pyramidal cells (Bernardi et al., 1982; Ferron et al., 
1984; Thierry et al., 1986; Peterson et al., 1987; Mantz et al., 1988; Yang & 
Mogenson, 1990; Karreman & Moghaddam, 1996). Despite this clear evidence of an 
inhibitory role of DA in the mPFC, the data in the literature suggest a more complex 
role of DA in the area. Thus, several findings suggest that the effect of DA on 
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prefrontal cells depends on the cell type and its state, i.e. the level of activity due to 
other inputs (for further information, see Tzschentke, 2001). 
Dopamine in general seems to have a non specific function and because of that, 
DA in the mPFC might play the same role in all the processes mentioned already for 
the NAc (Anselme, 2009). Today it is widely accepted that DA in the mPFC has a 
modulatory role and changes in the DAergic transmission in the area do not produce 
a clear behavioral output. 
Despite the fact that mesocortical DAergic system is the one with the higher 
responsiveness to stress, both acute and chronic, with respect to the other DAergic 
systems (Thierry et al., 1976; Blanc et al., 1980; Deutch et al., 1985; Jedema & 
Moghaddam, 1994; Cuadra et al., 1999), DA in the mPFC is also increased by other 
salient stimuli, such as novelty, food and conditioned to food stimuli (Feenstra & 
Botterblom, 1996; Bassareo & Di Chiara, 1997; Bassareo et al., 2002; 2007). 
As in the case of DA in the NAc, DA in the mPFC seems to play a role in reward 
processes as well, despite the fact that this role is not clear yet. Nevertheless, the 
increase of DA in the mPFC doesn’t seem to be induced by the consumption of a 
reward per se, but seems to be associated with “novelty, excitement, expectancy 
and operant and classical conditioned responses” and to code for generic 
motivational value (Bassareo & Di Chiara, 1997; Tzschentke, 2001; Bassareo et al., 
2002). Di Chiara and collegues suggest that unlike DA in the NAc, and the shell 
compartment in particular, DA in the mPFC is not related to the ability of some drugs 
to induce abusive behaviors. In fact, drugs that increase DA (or NA) preferentially in 
the mPFC are not abused by humans or they have low abuse potential (Tanda et al., 
1994, 1996; Bassareo et al., 1996).  
A great amount of work has been held out to unravel the role of DA in the mPFC 
in working memory, i.e. the ability to retain and manipulate information temporarily. 
Thus, the projection from VTA to mPFC is said to play a pivotal role in working 
memory function, as it has been demonstrated in studies with monkeys and rats 
performing the “delayed alternation task”, a test that measures the intact function 
of this higher order cognitive function. The ability of both D1 agonists and 
antagonists to impair performance suggests that the influence of D1 receptor 
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occupation on working memory follows an inverted U-shaped curve (Arnsten, 1997; 
Dreher & Burnod, 2002). The role of DA on working memory has been also 
repeatedly demonstrated in humans (Luciana et al., 1992) and predominantly in the 
PFC in non-human primates (Sawaguchi & Goldman-Rakic, 1994). As in the case of 
NAc DA regarding reward, several theories tried to explain the exact role and 
function of mesocortical DAergic projections in working memory. 
Briefly, Cohen and collegues (Servan-Schreiber et al., 1990; Cohen & Servan-
Schreiber, 1992; Braver et al., 1999) have proposed a model of DA function in the 
mPFC according to which DA serves to increase signal-to-noise ratio and that way to 
facilitate both excitatory and inhibitory inputs to the cells of this region. Dopamine’s 
role is to gate access of information to active memory, i.e. to provide updating of 
useful, task-relevant information but also to protect from irrelevant information 
interference. These effects occur in the synapse by “transient potentiation of both 
excitatory afferent and local inhibitory input”. According to this theory, cognitive 
deficits in disorders that are characterized from a cortical hypodopaminergic state as 
in schizophrenia result from a failure in “gating” incoming information, from an 
increase in “noise”. The “noise” results in disturbances in updating and maintaining 
important and context relevant information in the active/working memory – 
cognitive characteristics of vital importance for cognitive control (Braver et al., 
1999).  
In means of conjoining reward processes and higher order cognitive functions as 
working memory and decision making, Durstewitz and collegues proposed a 
different model (Durstewitz et al., 1999; Durstewitz & Seamans, 2002). According to 
these authors, DA in the mPFC serves to increase “the robustness of representations 
encoding goal-related information” by reducing the impact of intervening stimuli.  
As mentioned above in the section for DA system characteristics, DA in the mPFC 
is also released in phasic (“extrinsic modulation”, in terms of neural networking) and 
tonic (“intrinsic modulation”) fashions. The source of phasic release is the firing of 
DAergic neurons located in the VTA; tonic release is induced by glutamatergic 
synapses (by local glutamatergic networks in the mPFC or by subcortical efferents) 
on the DAergic terminals in the mPFC independent of VTA neurons’ firing (Takahata 
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& Moghaddam, 1998; Dreher & Burnod, 2002). Attempting to fit these release 
properties of DA in a model, Dreher & Burnod (2002), suggested that DA in the mPFC 
serves to induce a threshold that restricts excitatory inputs to pyramidal neurons. 
The phasic and tonic modes of release induce this restriction in different time scales 
- seconds and minutes/hours respectively. Thus, phasic DA is modeled as a 
temporary restricting threshold of the external inputs arriving on apical dendrites of 
mPFC that follows their presentation. On the other hand, the control of mPFC on the 
VTA neurons firing, serves for phasic DA release to adapt to the “temporal structure” 
and the requirements of the task being performed (Dreher & Purnod, 2002). 
Limited data exist regarding the role of DA in each subarea of the mPFC in 
behavior. Hitchcott and collegues (2007) have shown that DA in the ventral parts of 
the mPFC (i.e. the IL cortex) is necessary for adjustment of behavior in relation to 
outcome expectancy. Thus, when DA was injected in the IL cortex, instrumental 
behavior was sensitive to outcome devaluation; DA in this area promoted shifting of 
behavior from stimulus-response conditions to action-outcome associations. The 
authors discussed the possibility that DA in the IL part of the mPFC plays an 
important role in attentional processes and this in turn had major impact in the 
behavioral manifestations observed during their experiments (Hitchcott et al., 
2007). In another recent study, Naneix et al. (2009) made specific DAergic lesions in 
infralimbic and prelimbic cortices of adult rats. Using behavioral paradigms they 
showed that DAergic dennervation within each area is not necessary for the 
acquisition of an instrumental response to receive a reward. However, animals with 
DAergic lesions in the PL showed deficits to adapt their instrumental behavior to 
contingency changes between behavior expression and reward delivery. This might 
also be related to the role of DA in behavioral flexibility associated with DA in the 
mPFC (Naneix et al., 2009). More studies are necessary to clarify the role of DA in 
each subregion of the mPFC on several aspects of behavior. 
Concluding the data regarding the role of DA in the mPFC, it worth mentioning 
the fact that there are researchers that support that there is non-specific role of DA 
on behavior (see Anselme, 2009), which partially is true as can also be seen from the 
data mentioned above. Thus, it is suggested that DA can serve in all three major 
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functions where is supposed to be involved – motor, reward, cognitive – in a unitary 
mode in which the DA system serves to help the organism to “learn about, predict 
and respond appropriately to events that lead to reward” (Braver et al., 1999). 
 
 
A.4 Evidence of Interaction Between Cortical and Subcortical 
Dopamine  
 
Dopaminergic terminals arising from the VTA innervate the deep layers of mPFC 
pyramidal cells (Berger et al., 1991; Dreher & Burnod, 2002) which project through 
glutamatergic efferents to subcortical areas as the VTA and the NAc (Taber et al., 
1995; Carr et al., 1999). In addition, as already mentioned DA terminals from VTA 
synapse with GABAergic interneurons in the mPFC modulating their function (Penit-
Soria et al., 1987; Pirot et al., 1992). These structural characteristics serve to provide 
direct and indirect inhibitory control of DA from the VTA on the activity of pyramidal 
neurons of the mPFC which in turn modulates the activity of subcortical areas 
including NAc and VTA. Several studies have shown that mPFC and NAc strongly 
interact regarding DA transmission and subsequently in several aspects of behavior. 
Evidence for general cortical – subcortical interaction was provided by early 
studies which showed that damage in the rat cortex can enhance the locomotor 
activity induced by amphetamine (Adler, 1961; Iversen, 1971) and the stereotypies 
induced by apomorphine (Scatton et al., 1982).  
Further experiments pointed out a specific role of the prefrontal cortex in 
controlling subcortical DA. Thus, chemical or electrical stimulation of the mPFC was 
shown to increase the firing rate and to change the firing pattern of DA neurons in 
the VTA (Gariano & Groves, 1988; Chergui et al., 1993; Murase et al., 1993) and to 
increase DA levels in the NAc via N-methyl-D-aspartate (NMDA) receptor activation 
in the VTA (Taber et al., 1995; Taber & Fibiger, 1995; Karreman & Moghaddam, 
1996; You et al., 1998). Oppositely, temporary inactivation of the mPFC was shown 
to reduce firing rate and burst firing in DA neurons located in the VTA (Svensson & 
Tung, 1989; Murase et al., 1993). 
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Through these studies it was made clear that interaction between mPFC and 
subcortical areas as the NAc and the VTA exists. Furthermore, a great amount of 
evidence suggests that mPFC and NAc show opposite characteristics regarding 
DAergic transmission and the way DA is released in each area during several aspects 
of behavior. Regarding behavior, augmentation of DAergic transmission in the mPFC 
follows reduction in spontaneous or drug-induced locomotor behavior; when 
administered locally in the mPFC, apomorphine and amphetamine decrease 
spontaneous and amphetamine induced activity (Vezina et al., 1991; Broersen et al., 
1999; Lacroix et al., 2000). On the other hand, D1 antagonists injected in the mPFC 
increase the locomotion induced by intra-NAc amphetamine injections (Vezina et al., 
1991). While in these studies there was no effect on locomotion of the 
microinjections of the substances in the mPFC alone, in some other studies a mild 
increase in locomotion was reported after microinjections of amphetamine (Carr & 
White, 1986). Increasing the DA levels by intra-mPFC injections of DA reuptake 
inhibitors was also found to decrease novelty-induced locomotion, an effect 
mediated by both types of DA receptors (Radcliffe & Erwin, 1996) while in other 
studies is reported that only D1 receptors are involved in these phenomena (Lacroix 
et al., 2000). Finally, with respect to locomotion, it was found that systemic injection 
of cocaine induces positive correlation between locomotion and DA levels in NAc 
and negative correlation between locomotion and DA levels in the mPFC (Hedou et 
al., 1999).  
With respect to neurochemistry the pattern discussed above (increases of DA in 
the mPFC result in decreases in induced locomotion and vice versa) is observed also 
in DA concentrations: increasing DAergic transmission in the mPFC leads to 
decreased DAergic activity in the NAc and decreased DAergic transmission  in the 
mPFC produces increased levels of DAergic activity in the NAc. Thus, it has been 
shown that locally administered amphetamine, cocaine or apomorphine in the mPFC 
decrease the DA levels and DA metabolites in the NAc while DA antagonists have the 
opposite effect (Louilot et al., 1989; Jaskiw et al., 1991; Kolachana et al., 1995).  
Additional evidence was provided by combined behavioral and neurochemical 
data which revealed that acquisition of intravenous (i.v.) amphetamine self 
A.Introduction 
 
 
22 
 
administration (SA) increased DAergic activity in the NAc combined and decreased 
the extracellular DA in the mPFC (Piazza et al., 1991). Similarly, the inverse 
relationship between prefrontal and accumbal DA was observed by Vanderschuren 
and collegues (1999) who reported that sensitization occurs after a single injection of 
amphetamine and this effect induces an increase in locomotion and DA release in 
the NAc in response to a challenge injection. Sensitization was found to be depended 
on withdrawal duration – the bigger the withdrawal, the bigger the increase of DA 
and the locomotion induced by the challenge injection. Opposite effects were 
observed regarding mPFC DA (Vanderschuren et al., 1999). In the intracranial self 
stimulation (ICSS) paradigm it has been shown that miroinjections of a D1 or D2 
antagonists in the NAc, increase ICSS reward thresholds of VTA stimulation (i.e. make 
the stimulation less regarding) while injections in the mPFC decrease the threshold 
(Duvauchelle et al., 1992, 1998). 
 Studies utilizing 6-OHDA lesions of the mPFC are in line with these data and the 
animals that have been lesioned demonstrate higher behavioral and neurochemical 
(in terms of increases of DA in the NAc) responses to pharmacological and natural 
stimulation. Thus, lesioned animals demonstrate higher haloperidol induced tyrosine 
hydroxylase (TH) activity (Rosin et al., 1992) and enhanced amphetamine-induced 
(Banks & Gratton, 1995) and K+ stimulated (Thompson & Moss, 1995) DA release in 
the NAc. These lesions can induce enhanced motor stimulant and stereotyping 
responses after repeated injections of amphetamine (Banks & Gratton, 1995; Espejo 
& Miñano, 2001) and after acute injections of cocaine (Beyer & Steketee, 1999) or 
methylphenidate (Wanchoo et al., 2010). The effects of lesions seem to be specific 
for the DAergic responses of NAc since it has been reported that they do not affect 
the increase of DA in the striatum after amphetamine injections (King & Finlay, 
1995). The lesion-specific effect in NAc DAergic responsiveness could account for the 
results of the groups of Schenk (1991) and McGregor (1996) who showed that 
lesioned animals are more sensitive to the reinforcing effects of lower doses of 
cocaine (Schenk et al., 1991; McGregor et al., 1996). Nevertheless, Martin-Iverson 
and collegues (1986) reported that the lesions do not influence i.v. SA of cocaine. 
Similar results were obtained by Lecesse & Lyness (1987) regarding amphetamine 
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SA. Similarly contradictory are the results of SA studies where the D1 antagonist 
SCH23390 was injected in the mPFC. Thus, there was shown to have no effect on 
intracranial SA of cocaine when co-administered with cocaine (Goeders et al., 1986) 
but it was shown to reduce the rewarding effects of cocaine when it is self 
administered i.v. (McGregor & Roberts, 1995). These differences might be explained 
in terms of doses used, schedules tested and the diffusion of the substane. 
Ablation of DA in the mPFC appears to have profound effects on responses of 
animals to stressors i.e. they seem to increase the sensitivity of mesoaccumbal 
DAergic terminals to mild stressors. Thus, lesions induce increase of DA in the NAc 
which normally is not observed in response to a mild stressor (Deutch et al., 1990) or 
higher increases than sham operated animals (King et al., 1997). As in the case of 
drugs, the DAergic stimulation from stress in the lesioned animals seems to be 
selective for the NAc as no increases in DA were observed in the dorsal striatum 
after the stressor (Deutch et al., 1990; King & Finlay, 1995). A behavioral correlate 
for these findings might be the observation of Espejo (1997) that 6-OHDA lesions of 
the mPFC induce anxiogenic behavioral responses in rats under specific testing 
procedures. As in the case of stress, the lesions have been shown to enhance the 
mesolimbic DA release after repeated exposure to gustatory stimuli (Mitchell & 
Gratton, 1992). 
King et al. (1997) have demonstrated that the lesions have differential effect on 
NAc core & shell DA transmission. Thus, they showed that basal levels and stress 
induced increases of DA were not observed in the NAc core. On the other hand the 
lesions increased basal levels and augmented the stress-induced DA levels in the NAc 
shell. When administered systemically, amphetamine increased DA levels in the NAc 
shell of lesioned animals as in the case of control rats but, surprisingly, the lesions 
attenuated the DA increase in the NAc core.  
Several studies have shown that 6-OHDA lesions of the mPFC can increase the 
basal levels of DA and DA metabolites in subcortical areas as NAc and striatum 
(Carter & Pycock, 1978; 1980; Pycock et al., 1980; Martin-Iverson et al., 1986; 
Leccese & Lyness, 1987; Louilot et al., 1989; Kurachi et al., 1995). Some studies have 
even shown that there is increased local blood flow in the NAc and in the striatum 
A.Introduction 
 
 
24 
 
after the lesions, an observation which indicates increased metabolic activity in 
these areas (Suzuki et al., 1995). On the other hand there is also a considerable 
amount of publications where no differences in basal levels of DA and its metabolites 
in subcortical areas (mainly NAc and striatum) where observed between lesioned 
and sham operated animals (Joyce et al., 1983; Oades et al., 1986; Schenk et al., 
1991; Jones & Robbins, 1992; Rosin et al., 1992; Bubser, 1994; King & Finlay, 1995; 
McGregor et al., 1996). These contradictory findings could be explained in terms of 
methodological differences, for instance different doses of 6-OHDA and the 
coordinates used between the different laboratories which might result in different 
magnitude and extension of the lesion.  
In conclusion, all these data, apart from some discrepancies, suggest a strong 
interaction between cortical and subcortical DA, and especially between mPFC and 
NAc. Thus, it is observed that increased DAergic flow in one area results in decreased 
DAergic transmission to the other and vice versa, i.e. the decrease of DA in one area 
results in increases of DA in the other. These observations led to the suggestion that 
the mesocortical DAergic system exerts an inhibitory control on the mesolimbic 
DAergic transmission - DA in the mPFC acts as negative feedback in controlling DA in 
the NAc (Tzschentke, 2001). The mechanism for this relation is not totally clear yet 
but it is almost sure that involves the glutamatergic projections from the mPFC to 
the VTA. For instance, in the case of lesion studies, the increases in basal and 
induced DAergic transmission in the NAc might result due to the disinhibition of the 
glutamatergic pyramidal projecting neurons of the mPFC after the DA depletion. The 
increase of glutamate in subcortical areas would result to increase of phasic DA 
release on subcortical sites through stimulation of DAergic cell bodies (Grace, 1991). 
This influence of mPFC on VTA DA release could be mediated by direct glutamatergic 
synapses on DAergic VTA cells (McCormick et al., 1985; Overton & Clark, 1997) but 
also indirectly by prefrontal glutamatergic synapses on non DAergic cells in the VTA 
and with other regions as the pedunculopontine tegmental nucleus (PPTg) which has 
direct excitatory synapses with the VTA (Tzschentke, 2001). It is also possible that 
other neurotransmitter systems are involved. 
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The effect of the disturbances of DAergic transmission (and its subsequent 
inhibitory influence on subcortical DA) on behavior has been already discussed by 
others. Thus, it has been speculated that disruption of the DAergic inhibitory control 
of the mPFC could lead to stress-induced psychotic symptoms in schizophrenic 
patients (Weinberger, 1987), to increased vulnerability to the addictive effects of 
drugs (Deminière et al., 1989; Piazza et al., 1991) or to general alternations of the 
DAergic responses to “pharmacological or environmental challenges of the system” 
that lead to potentiation of reinforcer efficacy (McGregor et al., 1996).  
 
 
A.5 Aim of the studies 
 
Previous studies from our laboratory have demonstrated that first exposure to 
palatable food increases DAergic transmission in NAc shell and core and in the mPFC; 
second exposure to the same taste stimulus fails to increase DA in the NAc shell – a 
phenomenon termed one-trial habituation – while it still increases DA in the NAc 
core and in the mPFC (Bassareo & Di Chiara, 1997; Bassareo & Di Chiara, 1999; 
Bassareo et al., 2002). Thus, it has been proposed that DA in the NAc shell codes for 
novelty and salience of a stimulus while DA in the NAc core and in the mPFC codes 
for generic motivational value (Bassareo et al., 2002).  
While extracellular DA, as measured by positron emission tomography (PET) scan 
and microdialysis studies has been shown to be increased by drugs of abuse in rats, 
non human primates and humans, there exists a different pattern of influencing the 
DAergic release in the terminal regions of mesocortical and mesolimbic systems (Di 
Chiara, 2002). Thus, drugs of abuse, regardless of the contingency to the response to 
take the drug, preferentially increase DA in the NAc shell as compared to the core, 
but no one-trial habituation is observed to this increase (Pontieri et al., 1995, 1996; 
Pontieri et al., 1996; Cadoni et al., 2005; Lecca et al., 2006a,b, 2007). It has been 
suggested that these phenomena reflect abnormal Pavlovian learning regarding the 
conditioned stimuli paired with the drug intake (Di Chiara et al., 2004; Di Chiara, 
2005; Di Chiara & Bassareo, 2007). 
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In a recent study, we (De Luca et al., 2011a) observed that sensitization to 
morphine can alter the DAergic responses to gustatory stimuli (both appetitive and 
aversive). Thus, increased and delayed DAergic flow in the NAc core of the sensitized 
animals was elicited after the first exposure to the stimulus while after the second 
exposure to the same stimulus abolishment of the habituation phenomenon was 
observed in the NAc shell. The second exposure to the same stimulus also produced 
a higher increase of DA in NAc core and induced habituation in DA increase in the 
mPFC of sensitized to morphine animals. These long term changes in DAergic 
response of different terminal areas were proposed to have implications in 
motivational processes and probably to result in increased incentive arousal and 
learning (De Luca et al., 2011a). The results of these studies are schematically 
represented on the table A.1.  
As mentioned in the previous sections, DA in cortical and subcortical areas 
strongly interacts; DAergic transmission in the mPFC exerts an inhibitory tone in the 
NAc DA release. Studies utilizing 6-OHDA lesions of the mPFC have shown that after 
the lesions, the animals show sensitized like behaviors in response to chemical and 
natural stimuli. Since in the literature exists only one study on the DAergic responses 
of lesioned animals to gustatory stimuli (Mitchell & Gratton, 1992) and without the 
distinction of DA responses in NAc shell and core, we wanted to further investigate 
these phenomena. More specifically, we wanted to investigate the role of 6-OHDA 
lesions in the mPFC on the DAergic responses of NAc shell and core after the 1st and 
2
nd
 exposure to gustatory stimuli. Furthermore, we utilized behavioral experimental 
procedures to clarify the effects of the lesions on related aspects of behavior as 
locomotor activity and hedonic reactions. 
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Table A.1 Schematic representation of the results of previous studies from the laboratory           
(Bassareo et al., 2002; De Luca et al., 2011a) 
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B. Materials & Methods  
 
B.1 Subjects 
 
In all the experiments the subjects were male Sprague-Dawley rats weighing 250-
275 g (Charles River, Calco, Italy). They were housed in group of six per cage with 
standard food (MIL topi e ratti, GLP diets, Stefano Morini, S. Polo D'Enza, RE, Italy) 
and water ad libitum, for at least one week in the central animal room of the 
Toxicology Department of the University of Cagliari, under constant temperature (23 
C°), humidity (60%) and a 12 h light/dark cycle (light from 8 a.m. to 8 p.m.). All 
animal experimentation has been conducted in accordance with the statement 
revised and approved by the Society for Neuroscience in January 1995 and with the 
guidelines for care and use of experimental animals of the European Economic 
Commission (EEC Council 86/609; DL: 27.01.1992, N° 116).  
 
 
B.2 Substances 
 
Six-hydroxydopamine hydrochloride (6-OHDA, Sigma-Aldrich, Milan, Italy) was 
used to lesion the DAergic terminals in the mPFC. It was dissolved in saline 
containing 0.2 % ascorbic acid at a concentration of 4mg/ml. A total volume of 1 μl 
was microinjected in the mPFC for each one of the 4 microinjections at a constant 
rate of 0.2 μl per minute.   
Desipramine hydrochloride (DMI - desmethylimipramine, 25 mg/kg, i.p.; Sigma 
Chemical Co., St Louis, MO, USA) was administered 30 minutes prior anaesthesia to 
protect the NAergic terminals from the 6-OHDA toxicity (see below). It was dissolved 
in saline and injected in a volume of 3ml/kg body weight. 
The appetitive gustatory stimulus used in the study was a solution of chocolate 
syrup (Nesquik Squeeze
©
, Nestle, S.A., Vevey, Switzerland) and tap water (1:1). The 
chocolate syrup contained sucrose, water, cacao, corn syrup, citric acid, salt, 
potassium sorbate and artificial flavor and it was administered intraorally through a 
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cannula (see below). 
 
 
B.3 Microdialysis probe and oral catheter construction 
 
Due to the temporal distance between the 6-OHDA lesions and the microdialysis 
experiments, it was not possible to use probes of acute type because of gliosis 
formation around the probe (see below, section B.5.1) and the subsequent problems 
with DA recovery. Thus, after the 6-OHDA lesions, in the same operating session, the 
animals were also implanted with a guide cannula for microdialysis probes.  
The probes utilized were of vertical-concentric type and were constructed as 
previously described from Lecca et al. (2006). The whole construction was based on 
a Push–Pull connector (Plastics One) where two silica capillary [140 μm outside 
diameter (OD), 50 μm inside diameter (ID), Polymicrotechnologies Inc., Arizona, USA] 
were inserted and stabilized into the inlet and the outlet needles.  At the tip of the 
probe the capillaries were surrounded by AN69 membrane (Hospal, Dasco, Italy) 
stabilized by epoxy glue, with an active dialyzing portion of 1.5 mm (see figure B.1). 
The membrane was made from polyacrilonitril and met the criterions for use in 
microdialysis experiments: it was inactive, biocompatible and permitted the recovery 
of DA and other substances of small molecular weight (Horn & Engelmann, 2001). 
The probes protruded by 4 mm from the guide cannulae. 
 
 
 
 
Figure B.1 Chronic microdialysis probe 
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The oral catheters were constructed from a 22-gauge stainless steel needle and 
polyethylene (PE) tubing (Polyethylene tubing, Portex limited, Hythe, Kent, England - 
ID 0.58 mm and OD 0.96 mm). The 22-gauge stainless steel needle was cut on one side 
(length 2 cm), was blunted and inserted in the PE tubing which was ending with a 
perforated circular disk with a hole to permit the flow of the gustatory solution. 
 
 
B.4 Surgery 
 
Six-hydroxydopamine is a hydroxylated derivative of DA (see figure B.2) and the 
most commonly used neurotoxin for producing lesions of DAergic neurons. It was 
isolated for the first time by Senoh & Witkop on 1959 (1959a,b) and the first studies 
about its biological actions were carried out from the group of Porter and Stone 
(Porter et al., 1963; Stone et al., 1963) who showed that 6-OHDA decreases the 
amount of noradrenaline in the autonomous nerve system in the heart. There is 
evidence that 6-OHDA exists as an endogenous toxin in the rodent and human brain 
(Senoh & Witkop, 1959b; Andrew et al., 1993).  
 
 
 
 
Figure B.2 Chemical structure of six-hydroxydopamine (6-OHDA), dopamine (DA) & noradrenaline 
(NA) 
 
 
As can be seen in Figure B.2, the chemical structure of 6-OHDA is very similar to 
both DA and NA. Because of that, 6-OHDA is transferred by the DA and NA 
membrane reuptake transporters in the intracellular space of the catecholaminergic 
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neurons where it accumulates and produces its toxic effects (Schwarting & Huston, 
1996a). 
As it can be understood, a selective blocker for DA or NA transporter (DAT & NAT 
respectively), such as DMI and benztropine respectively, can be used to target 
DAergic or NAergic terminals more selectively. When greater toxicity is needed, it 
can be achieved by the use of a monoaminoxidase (MAO) inhibitor (e.g. pargyline) 
that prevents the degradation of the toxic metabolites of 6-OHDA by this enzyme.  
It has been shown, both in vivo and in vitro, that as soon as 6-OHDA enters the 
cell, due to its great instability, it gets quickly oxidized to produce a series of 
substances as free radicals and H2O2. These products are very toxic for the cell and 
can alter its vital functions affecting proteins, membrane lipids and nucleic acids. 
Subsequently the oxidative stress leads to cell death (Kumar et al., 1995; Schwarting 
& Huston, 1996b). Furthermore, 6-OHDA inhibits the mitochondrial respiratory chain 
complexes I & IV (Glinka et al., 1997). 
As in the case of DA, 6-OHDA cannot cross the blood brain barrier (BBB) and the 
toxin has to be delivered intracranially to act on the brain. The purpose of the 
present study was to specifically lesion the DAergic terminals in the mPFC region. As 
mentioned above, in order to spare noradrenergic terminals, the rats were treated 
with DMI (25 mg/kg, i.p.) 30 minutes prior to anaesthetic injection (chloral hydrate, 
250 mg/kg, 3ml/kg in distilled water, i.p., Carlo Erba, Italy).  
After anaesthetized, the animals were placed in a stereotaxic apparatus (David 
Kopf Instruments) and were subjected to two bilateral 6-OHDA (4μg/μl, 6-OHDA 
hydrochloride, Sigma, in 0.2 % ascorbic acid saline) or vehicle microinjections (0.2 
μl/min, 1 μl for each injection) in the mPFC [3.2/2.7 mm anterior from bregma, 
±0.6/±0.7 mm from midline and -5.0/-2.5 mm from dura with a flat scull (Paxinos & 
Watson, 2007 see figure B.3)]. The injector was left in place for additional 5 min to 
permit the diffusion of the toxin/vehicle. 
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Figure B.3 6-OHDA/vehicle infusion sites (adopted from Paxinos & Watson, 2007) 
 
 
After the toxin/vehicle injections, microdialysis probe guide cannulae (see figure 
B.4) were implanted above NAc shell (AP: 1.9, ML: 0.9 from bregma and V: -3.8 mm 
from dura) or core (AP: 1.2, ML: 1.7 from bregma and V: -3.6 from dura) according to 
the atlas of Paxinos and Watson (2007) and secured with glasionomeric cement (CX-
Plus, Shofu Inc., Tokyo, Japan). At the end of the surgery session the animals were 
housed in two and were brought back in the main colony room.  
 
 
 
Figure B.4 Guide cannula for microdialysis probes used in the studies 
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After one week of post-operative recovery, the animals were anesthetized 
(chloral hydrate, 240 mg/kg, 12ml/kg, i.p., Carlo Erba, Italy) and were implanted with 
intraoral catheters. The oral catheter was inserted at the level of the first molar and 
the PE tubing was passed along the skull (see figure B.5) where it was fixed with 
glasionomeric cement (CX-Plus, Shofu Inc., Tokyo, Japan) according to the method of 
De Luca et al. (2011a). After the operation the animals were put in hemispheric 
bowls.  
 
 
Figure B.5 Schematic representation of the position of implantation of the intraoral catheter in 
the rat 
 
After recovery from the anesthetic, animals belonging to the pre-exposed group 
were treated with the appetitive sweet solution (Nesquik Squeeze©-water 1:1, 1ml, 
0.2ml/min) and the rats belonging to the naïve group were treated intraorally with 
tap water. 
 
 
B.5 Microdialysis Studies 
 
B.5.A Introduction 
 
Microdialysis is used to measure concentration of compounds in the extracellular 
fluid of living tissue by means of an implanted microdialysis probe. In vivo brain 
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microdialysis is a method that permits the collections of samples from the 
extracellular space of any desired brain region while the animal is freely moving. 
Several experimental treatments (drug administration, environmental and 
behavioral manipulations) can be utilized to observe variations from the basal levels 
regarding several neurotransmitters – neuromodulators (Horn & Engelmann, 2001). 
The method of in vivo brain microdialysis is based on the diffusion of substances 
between the extracellular space in the brain and an artificial cerebrospinal fluid 
(ACSF – Ringer’s solution) through a microdialysis probe equipped with a 
semipermeable membrane (Ungersted, 1984; Hernandez et al., 1986; Di Chiara, 
1990). The diffusion takes place because of a concentration gradient between the 
cerebrospinal fluid (CSF) of the brain and an artificial one pumped at very low flow 
rate through the probe. The probe is implanted in the brain stereotaxically or is 
inserted through a guide cannula. Conversely, every substance that can pass through 
the semipermeable membrane can be delivered to the area where the probe is 
implanted, through the microdialysis probe. This method is called “retrodialysis” 
(Horn & Engelmann, 2001).  
The advantages of in vivo trancerebral microdialysis include the minimization of 
tissue damage and the avoidance of mechanical pressure of the brain region under 
investigation (the major disadvantage while using the older “push pull” method); the 
collection of relatively pure samples for analysis; the avoidance of disregulation of 
the electrolytic balance of the brain. In addition, in vivo microdialysis can be used in 
freely moving animals and so can help to associate alternations in behavior with 
changes in brain neurochemistry. Finally, the capability to administrate substance 
locally through the probe (see above – “retrodialysis”) can be a very useful tool for 
studying the effect of several substances on the region surrounding the probe. 
Retrodialysis avoids the high blood concentrations of the substance and its effects in 
non desired brain areas (Di Chiara, 1990; Westerink, 1995; Horn & Engelmann, 
2001).  
However, in vivo microdialysis is an invasive method in which “the external 
diameter of the probes is around one thousand times bigger than the synapses 
where a neurotransmitter is studied”, which means that the amount of substance in 
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a sample does not represent the released substance from the actual locus of release 
(Di Chiara, 1990). Another disadvantage of the method is that it cannot be used 
consecutively for more than 3-4 days due to glia formation and the subsequent 
blocking of the pores of the probe’s membrane. This limitation can be surpassed by 
using guide cannulae as in the present study. Finally, another limitation of the 
method is the poor time resolution, limitation that depends on the analysis 
equipment available in each laboratory (Westernick, 1995).  
Despite the fact that new methods for monitoring extracellular DA have been 
developed (e.g. in vivo voltammetry) microdialysis is still a useful tool for monitoring 
changes in DA levels in a time frame of minutes. So the method monitors the DA 
levels that correspond to the tonic modality of DA release (see first part, section A.1) 
where methods as in vivo voltammetry monitor the phasic release of DA (Di Chiara & 
Bassareo, 2007). 
During microdialysis experiments the samples can be analyzed using a variety of 
methods. In the present study I used the method proposed by Imperato & Di Chiara 
(1984), i.e. the direct injection of samples in a High Performance Liquid 
Chromatography (HPLC) apparatus equipped with a reverse phase column and a 
coulometric detector (ESA, Coulochem II, Bedford, MA) for quantification of 
neurotransmitters. It has been shown to be a reliable and suitable method for the in 
vivo study of neurotransmitter release and their metabolites (Imperato & Di Chiara, 
1984). 
The HPLC apparatus consists of a mobile (buffer solution) and a solid phase 
(column). The mobile phase “pushes” the sample to pass through a chromatography 
column containing particles that interact differently with each substance and this 
way affecting their retention time, i.e time needed to move out from the column. 
After retention the substance is quantified. The lab where the experiments took 
place was equipped with an HPLC adjusted to an electrochemical detector for the 
quantification of DA. Thus, after separated from other substances, DA was oxidized 
and then reduced for the production of a chromatographic peak. The unknown peak 
was compared to a peak of a known size, so the DA in the sample could be 
quantified. 
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In particular, during the experiments of the present study, the levels of DA in the 
NAc shell and core of 6-OHDA and sham operated animals were monitored during 
basal conditions and after intraoral (i.o.) chocolate infusion. Thus, on the day 
following of the intraoral catheter implantation, concentric microdialysis  probes 
(Lecca et al., 2006b see also above section B.3) were inserted by hand through the 
guide cannulae, connected to an infusion pump and perfused with Ringer's solution 
(147 mM NaCl, 4 mM KCl, 2.2 mM CaCl2) at a constant rate of 1 µl/min. Samples 
were starting being collected approximately 30 min after the connection of the 
probes to the pumps for the counterbalancing of the flow through the probe. 
Thereafter, dialysate samples of 10 µl were taken every 10 min and immediately 
injected into a high-performance liquid chromatography equipped with a reverse 
phase column (LC-18 DB, 15 cm, 5 µm particle size, Supelco) and a coulometric 
detector (ESA, Coulochem II, Bedford, MA) to quantify DA. The first electrode of the 
detector was set at + 125 mV (oxidation) and the second at - 175 mV (reduction). 
The composition of the mobile phase was: 50 mM NaH2PO4, 0.1 mM Na2-EDTA, 0.5 
mM n-octyl sodium sulfate, 15% (v/v) methanol, pH 5.5 and was pumped by a Jasco 
pump (Cremella, LC, Italy). The sensitivity of the assay for DA was 5 fmol/sample.  
When DA in three consecutive samples didn’t differ more than 10 %, the values 
were considered as the basal levels of DA and the animal was treated with a sweet 
solution (Nesquik Squeeze
©
-water 1:1, 1ml, 0.2ml/min). Dopamine levels were being 
monitored for two more hours after the treatment. 
 
 
B.5.B Histology 
 
At the end of the microdialysis experiment, a group of rats was sacrificed by a 
lethal dose of saturated chloral hydrate solution (3ml/kg, i.p.). The guide cannulae 
were removed and the brains were extracted and placed on a frozen saline surface. 
The hemisphere in which the guide cannula was implanted was dissected and was 
later cut by a vibratome (Vibratome, Campden Instruments, 2Biological Instruments, 
Besozzo, Italy) in serial coronal slices (100 μm thick) at the level of NAc, oriented 
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according to the atlas of Paxinos & Watson (2007). The sections were put in well 
plates, examined under a microscope and the location of the probes was 
reconstructed and referred to the atlas of Paxinos & Watson (2007) (see figure B.6). 
The brain hemisphere without the probe and the mPFC specifically, was processed 
for the quantification of neurotransmitters in the tissue in order to evaluate the 
magnitude of 6-OHDA lesion (see below). 
 
 
Figure B.6 Localization of dialysis probes (dialysis portion) within the NAc with shell and core 
compartments (A - anterior coordinate; CPU - caudate putamen; Co - NAc core; Sh - NAc shell 
Reconstructed from Paxinos & Watson, 2007) 
 
Another group of the subjects was deeply anaesthetized with chloral hydrate 
(saturated solution) and transcardially perfused with 50ml of saline, followed by 
100ml of paraformaldehyde (PFA) solution (4 % in Phospate Buffer Solution - PBS).  
The aim of the perfusion procedure is to remove the blood from the brain and to 
fix the tissue. Briefly, after the animal is anaesthetized, the thorax is withdrawn and 
the stern is cut in a manner that the beating heart of the animal is exposed. A small 
dissection is made in the right atrium of the heart and from the left ventricle is 
administered firstly the saline and then the PFA solution. The heart works as a 
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“pump” and provides to the systemic circulation the saline and the PFA solution to 
remove all the blood from the body. After the procedure, the brains of the subjects 
were removed and the hemisphere implanted with guide cannula was stored and 
processed for histological examination as described above. The rest of the brain was 
postfixed (in 4 % PFA in PBS) for the immunohistochemical studies (see below).  
Only animals with correct implantation of the probe were included in the 
statistical analysis.  
 
 
B.6 Behavioral Studies 
 
B.6.1 Taste Reactivity Test  
  
Taste reactivity test has been utilized as an operational estimate of hedonic 
valence (positive or negative) and hedonic impact of tastes (Grill & Norgren, 1978; 
Berridge, 2000). This behavioral test was introduced by Grill and Norgren on 1978. 
They showed that passive deliverance of solutions in the mouth of rats produces 
particular behavioral reactions to each one solution, reproducible between subjects. 
Thus, palatable solutions (e.g. sucrose solutions) elicit a series of stereotype hedonic 
reactions to rats: lateral and rhythmic tongue protrusions, paw licks, face washing 
and increases in locomotion (see figure B.7). Bitter tastes, as quinine solution, elicit 
typical aversive reactions:  gapes, chin rubs, face washing, flailing of the forelimbs 
and paw tread (see figure B.8). After neutral solutions, neutral reactions were 
observed: rhythmic mouth movements and passive drip of the solution (Grill & 
Norgren, 1978; Berridge, 2000; Bassareo et al., 2002; De Luca et al., 2011a,b).  
 
 
 
 
 
 
B.Materials & Methods 
 
 
39 
 
 
 
 
Α)                 Β) 
 
 
 
                         
 
 
Figure B.7 Hedonic Reactions to appetitive stimuli: A) tongue protrusion, B) paw licks (unpublished 
photographs from the archives of the laboratory of the Department of Toxicology of the University of 
Cagliari) 
 
A)               B) 
                                                   
 
Figure B.8 Typical aversive reactions: A) chin rub, B) gape (unpublished photographs from the 
archives of the laboratory of the Department of Toxicology of the University of Cagliari)   
 
Interestingly, it has been shown that these typical taste reactions to palatable and 
aversive stimuli can be observed in other species as well; they have been shown to 
be homologous between rats, human and other primate infants (Steiner et al., 
2001). Thus, it is suggested that the taste reactivity test can be utilized for the direct 
assessment of the hedonic value of gustatory stimuli and to dissociate “liking” and 
“wanting” for a gustatory stimulus which are distinct behavioral characteristics that 
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their nature generated excessive debate in the past, regarding their recording and 
measurement (Berridge, 1996; Berridge, 2000). 
In the present study, behavior was recorded during the infusion of solutions 
through the oral catheter at the same session when the microdialysis study was 
taking place. The oral catheter was connected to an infusion pump and a solution 
(chocolate, quinine or tap water) was pumped at a constant rate of 0.2ml/min, for a 
total amount of 1ml. During the taste reactivity test the animals were videotaped 
and the positive hedonic (ingestive) taste reactivity patterns were scored. Positive 
hedonic reactions consisted of lateral and rhythmic tongue protrusions, paw licks, 
face washing and locomotion (Grill & Norgren, 1978; Berridge & Robinson, 1998). 
Each lateral and rhythmic tongue protrusion was counted as individual event and 
each event was scored with one point. The rest of the events were scored with one 
point if the duration of the event was between 1 and 5 seconds and with two points 
if the duration of the event was more than 5 seconds. 
 
 
B.6.2 Estimation of Motor Activity  
 
Locomotor activity is associated with a great number of other types of behavior 
and because of that it is of high importance for the organism. Studying locomotor 
activity in intact subjects can provide substantial information about the 
neurobiological substrate of this behavior, as long as for the reasons of causing 
motor deficits. In rodents, measures of locomotor activity can provide important 
information on potential mechanisms of drug action. The functional outcome of this 
behavior can be influenced by a variety of experimental manipulations with models 
of CNS injury or disease included. The study of locomotor activity can also provide 
information about learning and memory processes but also about anxiety (Decker, 
2001).  
In the present study, the subjects that participated in the studies of motor activity 
were subjected to 6-OHDA lesions or sham operations as described above (see 
section B.4). As in the case of microdialysis studies, one week after the lesions the 
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animals were anesthetized again, were implanted with intraoral catheters and, after 
recovery from the anesthetic, the rats that belonged to the pre-exposed group were 
treated with the appetitive sweet solution (Nesquik Squeeze©-water 1:1, 1ml, 
0.2ml/min) while the ones that belonged to the naive group were treated intraorally 
with tap water. 
The estimation of motor activity was taking place the next day from the intraoral 
cannula implantation in a quiet, isolated room. The rats were place in the room 30 
minutes before the experiment in order to get familiar with the novel environment. 
After this period they were put individually in the motility chambers.  
The measurement of the motor activity was recorded automatically in cages 
equipped with two pairs of infrared photocell emitters and detectors situated along 
the long axis of each cage (Opto-Varimex; Columbus Instruments, Columbus, Ohio, 
USA). Interruption of a photocell beam was detected by a counter that recorded the 
total number of photocell beam interruptions. The counter recorded two types of 
motor activity: locomotor (ambulatory) activity, due to the locomotion of the rat 
along the long axis of the cage, and total motor activity, which represented 
locomotor activity plus non-finalized movements. The counter recognized the 
stereotyped movements because of the continuous interruption of the same 
photocell beam, whereas locomotor activity along the cage produced interruption of 
different photocell beams. 
For half an hour (habituation period) the motor activity was recorder and these 
values were considered to represent the basalmotor activity. After that period of 
time the rats were treated with the chocolate solution or tap water (1ml/5min, i.o.) 
and their locomotor and total motor behavior was recorded for 30 more minutes. 
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B.7 Lesion Evaluation 
 
B.7.1 Concentration of neurotransmitters in the tissue – Introduction 
 
Regional tissue levels of neurotransmitters were measured in order to evaluate 
the magnitude of lesion and the impact of 6-OHDA injections on other 
neurotransmitter systems. The method described below is used to quantify 
neurotransmitters located in the intracellular space.  
After the end of the experiments, a group of rats was sacrificed by a lethal dose of 
saturated chloral hydrate solution (3ml/kg, i.p.) as described above. From the rats 
participated in the microdialysis studies the guide cannulae were removed and the 
brains were extracted and placed on a frozen saline surface. The hemisphere in 
which the guide cannula was implanted was dissected and subjected to histological 
examination as described in the section B.5.B. 
From the hemisphere without probe implanted and from the brains of a group of 
rats participated in the motor activity studies, the olfactory tubercules were 
removed and a coronal cut was made at 4.20 mm AP from bregma, using the “Rat 
Brain Atlas” as a reference (Paxinos & Watson, 2007). An additional coronal cut was 
made at 3.00 mm AP from bregma. From the latter remaining slice the mPFC was 
isolated, i.e. the IL, PL and Cg1 cortices (see part A, section A.3.1) and stored in 1ml 
vials.  
The samples were sonicated in 250 μl of 0.2 M perchloric acid for 15 seconds in 
order to be homogenized. Then, they were centrifugated at 11000 spins per min for 
15 min at 4° C and the supernatant was filtered (0.6 μm). After filtration, 20 μl 
samples were injected into an HPLC apparatus equipped with a reversed-phase 
column (C8, 3.5 μm particle sizes, Waters, Milford, MA, USA) and a coulomentric 
detector (Coulochem II, ESA Inc., Bedford, MA, USA) to quantify simultaneously NA, 
DA and 5-HT. The first electrode was set at -90 mV and the second electrode at +280 
mV. The composition of the mobile phase was 75 mM NaH2PO4, 20 mM EDTA, 1 mM 
sodiumdecanesulphonate, 0.01% triethylamine and 15% methanol (pH 5.70) and was 
pumped through the column with a Jasco pump (Cremella, LC, Italy). 
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B.7.2 Immunohistochemistry Studies – Introduction 
 
As described above, a group of the rats participated in the microdialysis 
experiments and another from those participated in the motor activity studies was 
deeply anesthetized with chloral hydrate (240 mg/kg, i.p.) and transcardially 
perfused with 50ml of saline, followed by 100ml of 4% paraformaldehyde solution. 
The brains were then removed and the hemisphere with the guide cannula from the 
rats participated in the microdialysis experiments was dissected and stored for 
histological examination (see above, section B.5.B). The other hemisphere, or the 
entire brain in the case of the rats participated in the motor activity studies, was 
postfixed for 2 days in PFA solution (4 % in PBS).  
After 2 days, the brains were cut in 40-μm-thick serial coronal slices on a 
vibratome (Technical Products International, St Louis, MO, USA) which then were 
processed for tyrosine hydroxylase (TH) immunohistohemistry.  
Immunohistochemistry is a technique that combines methods from immunology, 
histology and biochemistry and is used for the detection and study of distribution of 
several proteins in cells or tissues. It is based on the principal of the specific binding 
between antibody and antigen. Experiments using immunohistochemistry were 
described for the first time in 1940’s but from that time the method has been 
modified to optimize efficiency regarding the protein binding and tissue fixation and 
the methods for tracing and counting the signal. Today, the most common practice is 
to use antibodies that are conjugated to an enzyme or to a fluorophore. In the first 
case, which was also used in the present experiments, after the antigen-antibody 
binding, the enzyme reacts with a specific substrate to produce a color that can be 
observed under an ordinary light microscope. In our case that enzyme was 
horseradish peroxidase (HRP) (Bolak & Van Noorden, 2003). The chromogenic 
substrate for HRP was 3,3'-diaminobenzidine (DAB) which produced a light brown 
coloration of the TH-positive fibers. 
Signal amplification is of crucial importance for the analysis of the images. In the 
present study, indirect immunohistochemistry method was used, which means that 
a specific antibody binds to the target protein, which in turn binds to several 
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secondary antibodies conjugated to HRP to produce coloration. For further signal 
amplification can be used several other methods as the so called biotin-avidin 
complex (ABC), which was also used in the present study. According to this method, 
the secondary antibody is biotinylated and incubated to labeled (with the enzyme – 
in our case HRP) avidin-biotin reagent, in order to form large complexes with great 
numbers of the enzyme. As a result, the enzyme in presence of DAB produce higher 
amount of coloration visible to be analyzed (see figure B.9) (Ramos-Vara, 2005). 
 
 
 
Figure B.9 Schematical representation of the immunohistochemical reaction 
 (from Ramos-Vara, 2005) 
 
In the present study, free floating immunohistochemistry was used with a 
monoclonal antibody specific for tyrosin hydroxylase (TH) for visualizing the DAergic 
terminals/fibers in the mPFC of lesioned and sham operated animals.  
The 40-μm-thick serial sections of the mPFC (see above) were put in well plates 
and then rinsed for 10 min in  
1. tris-buffered saline 50 mM (TBS) and Triton X-100 0.1%  
2. TBS and Triton X-100 0.1%, containing H2O2 (0.85% p/v)  
3. TBS and Triton X-100 0.1% and  
4. 5% normal donkey serum (NDS) (Jackson Immunoresearch, EU, UK) in TBS and 
Triton X-100 0.1%.  
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Triton X-100 is a deterget which is used to reduce surface tension and 
subsequently to allow the use of less reagent to achieve better coverage of the 
sample. The samples were incubated with normal donkey serum in order to block 
the reactive sites to which the primary or secondary antibodies may otherwise bind 
to and so to reduce background staining.  
After the procedure described above, the sections were incubated for 40 h with a 
mouse monoclonal primary antibody against TH (T1299, Sigma) at a dilution of 
1:1000 in TBS. The reaction was amplified using biotinylated secondary antisera 
(Jackson Immunoresearch, EU, UK) and visualized by standard avidin–biotin–HRP 
(Vector Laboratories). Staining was obtained by the oxidation of peroxidases induced 
by H2O2 in the presence of DAB (Sigma). After 3 rinses of 10 min each in TBS, the 
sections were mounted on super frost plus glass slides (Thermo Scientific).  
After drying and dehydrating with ascending series of alcohols, sections were 
mounted with Eukitt (Fluka) and examined through a Zeiss AxioScope.A1.  
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C. Results 
 
C.1 Microdialysis Studies 
Basal values 
 
Basal values of DA, expressed as fmoles/10-μl sample (mean±SEM), were: NAc 
shell of sham 38±3 (n=14), NAc shell of lesioned 43±5 (n=14), NAc core of sham 48±6 
(n=11), NAc core of lesioned animals 47±5 (n=14). 
 
Effect of mPFC 6-OHDA lesion on the NAc shell DA responsiveness to chocolate in 
naive or pre-exposed rats 
 
Panel A of figure C.1 shows that chocolate (1ml/5min, i.o.) increased NAc shell 
extracellular DA both in sham and in 6-OHDA lesioned naive animals. Two-way 
ANOVA revealed a significant effect of time [F(12,180)=6.33; p<0.001]. Tukey’s post hoc 
test revealed a statistically significant increase in DA with respect to basal values 10 
minutes after chocolate in the lesioned group; no statistical significant differences 
between the two groups were observed.    
Panel B of figure C.1 shows the effect of i.o. infusion of chocolate on NAc shell DA 
of sham and 6-OHDA lesioned in the mPFC animals, pre-exposed to chocolate. Two-
way ANOVA showed a significant effect of group [F(1,13)=6.42; p<0.03] and time 
[F(12,156)=2.05; p<0.03]. Tukey’s post hoc test revealed a significant increase of DA 
with respect to basal values 10 minutes after chocolate in the lesioned group and a 
statistically significant difference between the lesioned and sham groups in the same 
period of time.    
Two-way ANOVA between sham naive and sham pre-exposed groups showed a 
significant effect of group [F(1,13)=9.74; p<0.01], time [F(12,156)=4.22; p<0.001] and 
group x time interaction [F(12,156)=2.65; p<0.01]. Tukey’s post hoc test revealed 
significant differences in DA levels between the groups at 10 and 20 min after 
chocolate treatment. In the lesioned animals, two-way ANOVA between naive and 
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pre-exposed animals revealed a significant effect of time [F(12,180)=4.07; p<0.001] but 
no differences between the groups.  
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Figure C.1 Effect of i.o. chocolate on DA transmission in NAc shell in sham (circles) and 6-OHDA 
lesioned (triangles) in naive (panel A) and 24-h taste pre-exposed animals (panel B). Results are 
expressed as mean±SEM of change in DA extracellular levels expressed as percentage of basal values. 
The arrow indicates the start of chocolate infusion (C, 1ml/5 min). Solid symbols: p<0.05 vs. the 
respective basal values (two-way ANOVA); *p<0.05 vs. sham pre-exposed group; #p<0.05 vs. sham 
naive group (two-way ANOVA) (sham naive n=6, lesioned naive n=11, sham pre-exposed n=9, lesioned 
pre-exposed n=6) 
 
 
Effect of mPFC 6-OHDA lesions on the NAc core DA responsiveness to chocolate in 
naive or pre-exposed rats 
 
Panel A of figure C.2 shows that chocolate (1ml/5min, i.o.) increased NAc core 
extracellular DA both in sham and in 6-OHDA lesioned naive animals. Two-way 
ANOVA revealed a significant effect of group [F(1,12)=8.66; p<0.02], time 
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[F(12,144)=4.33; p<0.001] and group x time interaction [F(12,144)=3.58; p<0.001]. Tukey’s 
post hoc test revealed a statistically significant increase in DA with respect to basal 
values after chocolate in the lesioned group and statistically significant differences in 
the DA levels between the groups.    
Panel B of figure C.2 shows the effect of i.o. infusion of chocolate on NAc core DA 
of sham and 6-OHDA lesioned in the mPFC animals pre-exposed to chocolate. Two-
way ANOVA showed a significant effect of time [F(12,192)=5.75; p<0.001]. Tukey’s post 
hoc test didn’t reveal any statistically significant differences between the groups.  
Two-way ANOVA between sham naive and sham pre-exposed groups showed a 
significant effect of time [F(12,156)=3.32; p<0.001] but no statistically significant 
differences between the groups. In the group of lesioned animals, two-way ANOVA 
between naive and pre-exposed rats revealed a significant effect of group 
[F(1,15)=11,41; p<0.005],  time [F(12,180)=5.71; p<0.001] and group x time interaction 
[F(12,180)=4.96; p<0.001]. Tukey’s post hoc test revealed statistically significant 
differences between the groups. 
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Figure C.2 Effect of i.o. chocolate on DA transmission in NAc core in sham (circles) and 6-OHDA 
lesioned (triangles) in naive (panel A) and 24-h taste pre-exposed animals (panel B). Results are 
expressed as mean±SEM of change in DA extracellular levels expressed as the percentage of basal 
values. The arrow indicates the start of chocolate infusion (C, 1ml/5 min). Solid symbols: p<0.05 vs. 
the respective basal values (two-way ANOVA); *p<0.05 vs. sham naive group; #p<0.05 vs. sham naive 
group (two way ANOVA); (sham naive n=8, lesioned naive n=6, sham pre-exposed n=7, lesioned pre-
exposed n=11) 
 
 
C.2 Behavioral Studies 
 
C.2.1 Taste Reactivity Test 
  
Effect of 6-OHDA lesions in mPFC on taste reactivity to chocolate in naive and taste 
pre-exposed rats 
 
Behavioral taste reactions to chocolate in naive sham, naive lesioned, pre-
exposed sham and pre-exposed lesioned rats during the microdialysis experiment 
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are shown in figure C.3. Unpaired t-test did not show any statistical significant 
differences between sham naive and sham pre-exposed, lesioned naive and lesioned 
pre-exposed, sham naive and lesioned naive and between sham pre-exposed and 
lesioned pre-exposed animals.  
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Figure C.3 Behavioral appetitive score to chocolate in sham (clear bars) or 6-OHDA lesioned in the 
mPFC rats (black bars), naive or 24-h pre-exposed to taste. Results are expressed as mean±SEM of 
behavioral score; (sham naive n=22, sham pre-exposed n=18, lesioned naive n=27, lesioned pre-
exposed n=16) 
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C.2.2 Estimation of Motor activity  
 
Effect of 6-OHDA lesions in the mPFC on basal and chocolate-induced locomotor 
and total motor activity 
 
Cortical DA depletion did not produce differences during the habituation period in 
total motor (panel A) and locomotor (panel B) activity (unpaired t-test) as shown in 
figure C.4.  
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Figure C.4 Total motor (panel A) and locomotor activity (panel B) during the 30-minutes habituation 
period of sham (clear bars) and lesioned (filled bars) animals, naive (left) and pre-exposed (right) to 
chocolate. Results are expressed as mean±SEM photocell counts in 30 minutes (sham naïve: n=10; 
lesioned naïve: n=8; sham pre-exposed: n=7, lesioned pre-exposed: n=5). 
 
In figure C.5 is represented the time course of total motor (panel A) and 
locomotive activity (panel B) after chocolate in sham naive, sham pre-exposed, 
lesioned naive and lesioned pre-exposed animals. Two-way ANOVA revealed a 
significant effect of time [F(6,156)=7.71; p<0.001 for total motor and F(6,156)=5.42; 
p<0.001 for locomotor activity] but no differences between the groups were 
revealed. Figure C.6 represents the overall total motor (panel A) and locomotor 
activity (panel B) during the 30 minute observation period after the chocolate 
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treatment. Unpaired t-test didn’t reveal any statistical differences between the 
groups. 
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Figure C.5 Time course of total motor (panel A) and locomotor activity (panel B) during the 30-
minutes observation period after chocolate treatment (1ml/5min, i.o.) of sham naive (squares, n=10), 
lesioned naive (triangles, n=8), sham pre-exposed (inverted triangles, n=7) and lesioned pre-exposed 
animals (rhombs, n=5) in 5 minute intervals. Results are expressed as mean±SEM photocell counts in 
30 minutes after chocolate treatment. The arrow indicates the start of chocolate infusion (C, 1ml/5 
min). 
 
0
250
500
750
Sham
Lesioned
Naive Pre-exposed
Total motor activity after chocolate
co
u
n
ts
 
in
 
30
 
m
in
u
te
s
0
250
500
750
Naive Pre-exposed
Sham
Lesioned
Locomotor activity after chocolate
Co
u
n
ts
 
in
 
30
 
m
in
u
te
s
Overall total motor and locomotor activity after chocolate
A B
 
Figure C.6 Overall total motor (panel A) and locomotor activity (panel B) after chocolate treatment 
during the 30-minutes observation period of sham (clear bars) and lesioned (filled bars) animals, naive 
(left) and pre-exposed (right) to chocolate. Results are expressed as mean±SEM photocell counts in 30 
minutes (sham naïve: n=10; lesioned naïve: n=8; sham pre-exposed: n=7, lesioned pre-exposed: n=5). 
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C.3 Lesion Evaluation 
 
C.3.1 Concentration of neurotransmitters in the mPFC  
 
Table C.1 shows the NA, DA and 5-HT tissue levels in the mPFC in sham and 6-
OHDA lesioned rats and the subsequent percentage of depletion. Six-
hydroxydopamine  lesions produced a significant decrease in DA concentration (68% 
of depletion, unpaired t-test) but didn’t produce a statistically significant effect on 
NA and 5-HT levels (14 and 10% depletion respectively) due to the protective effect 
of DMI pretreatment. 
 
 
Table C.1 Tissue levels (pg/mg wet tissue weight) and percentage of depletion of noradrenaline, 
dopamine and serotonin in the mPFC of 6-OHDA and sham operated rats. 
 
Group Noradrenaline Dopamine Serotonin 
Sham 
 132,8 ± 12,71 
(N=18) 
52,88 ± 7,88 
(N=18) 
 193,6 ± 20,05 
(N=18) 
6-OHDA 
113,9 ± 11,24 
(N=20) 
 17,13 ±  4,32 
(N=20) 
 175,2 ± 17,93 
(N=20) 
% depletion 14% 68%* 10% 
 
Means±SEM; * p<0.001 compared to sham operated animals (unpaired t-test) 
 
 
 
 
 
 
 
 
 
 
C.Results 
 
54 
 
C.3.2 Immunohistochemistry Studies – Images 
 
 
100 μm
100 μm 500 μm
 
 
Image C.1 TH reactivity in infralimbic (lower rectangle) and prelimbic (upper rectangle) of a sham 
operated rat 
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Image C.2 TH reactivity in infralimbic (lower rectangle) and prelimbic (upper rectangle) of a 6-OHDA 
lesioned rat 
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D. Discussion 
 
The main findings of the present study are that 6-OHDA lesions of the mPFC alter 
NAc DA responsiveness to gustatory stimuli. While in the NAc shell of naive subjects 
the lesion did not produce any effect, in the NAc core resulted in a higher and 
delayed increase of DA in response to chocolate. On the contrary, in chocolate-pre-
exposed subjects the lesion did not have any effect on NAc core DA responsiveness 
to chocolate but it abolished one-trial habituation of NAc shell DA response to taste. 
Therefore, the first exposure to chocolate induced a higher increase of DA in the 
core and a normal increase in the shell; the second exposure abolished the 
habituation of NAc shell DA and prevented the increase of DA in the NAc core 
observed after the first exposure to the taste stimulus. It appears as if the lesion 
abolished habituation in the shell while induced it in the core. 
The studies described in the present thesis used a protocol of 6-OHDA lesion of 
the mPFC as reported by Beyer and Stekette (1999). Quantification of the mPFC 
tissue content of NA, DA and 5-HT showed that despite the fact that there was a 
reduction of all neurotransmitter levels in the lesioned group with respect to the 
sham operated animals (14, 68 and 10% for NA, DA and 5-HT, respectively) this 
reduction was statistically significant only in the case of DA. That indicates that 
treatment with DMI, which blocks the NAT, successfully protected NAergic terminals 
from 6-OHDA toxicity. Unlike Beyer & Stekette (1999) we did not observe a 
statistically significant reduction in 5-HT levels. The fact that there was a high 
reduction in DA levels without significant lesions of NA and 5-HT indicated that the 
results obtained are due to the disruption of the DAergic transmission in the mPFC. 
Furthermore, the images from the immunohistochemistry studies (images  C.1 
and C.2) and the fact that no differences were observed between lesioned and sham 
operated animals on the basal DA levels in the microdialysis experiments indicates 
that the lesion was restricted to the mPFC and didn’t affect subcortical DA, 
particularly in the NAc. This was expected because the coordinates used provide a 
sufficient distance from the NAc (Beyer & Stekette, 1999). Previous studies in rats 
and monkeys report increased in DA levels and DA turnover in subcortical areas as 
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NAc and striatum (Carter & Pycock, 1978, 1980; Pycock et al., 1980; Martin-Iverson 
et al., 1986; Lecesse & Lyness, 1987; Haroutunian et al., 1988; Kolachana et al., 
1995; Kurachi et al., 1995; Roberts et al., 1994; Sokolowski & Salamone, 1994) or 
no effect (Joyce et al., 1983; Oades et al., 1986; Schenk et al., 1991; Jones & 
Robbins, 1992; Rosin et al., 1992; Bubser, 1994; McGregor et al., 1996). In our case, 
as already mentioned, no differences were observed in the basal levels of DA in the 
NAc shell and core between the sham and 6-OHDA lesioned animals. In agreement 
with this, no differences were observed in TH density between the groups (images 
C.1 and C.2). These discrepancies can be explained by experimental differences such 
as the dose of 6-OHDA utilized, the number of injections within the mPFC, the speed 
of infusion of the toxin and the coordinates. 
As in the case of basal DA levels, the data in the literature regarding basal levels of 
motor activity are inconsistent. Thus, there have been reported increases (Carter & 
Pycock, 1980; Espejo & Miñano, 2001), no effects (Oades et al., 1986; Beyer & 
Steketee, 1999; Wanchoo et al., 2010) or even decreases (Espejo, 1997) in basal 
locomotor activity after 6-OHDA lesions in the mPFC. In our case, we did not observe 
any difference in total motor or locomotor activity between sham and lesioned 
animals during the 30 min habituation period. These levels of activity reflect the 
basal motor activity levels. In addition we did not observe any differences in motor 
activity after exposure to chocolate. Despite the fact that there was a tendency for 
total motor and locomotor activity augmentations in different time frames between  
sham and lesioned groups after chocolate treatment, the statistical analysis did not 
reveal any significant effects. These findings are in contrast with pharmacological 
studies that report increased levels of locomotion in the lesioned animals (Beyer & 
Steketee, 1999; Wanchoo et al., 2010). This could be explained by the fact that 
drugs of abuse and natural reinforcing stimuli as food, despite the fact that share 
some common neural substrates, they also have major differences in terms of 
intensity and duration of the effects but also regarding the locus of action with the 
neural substrates of basal activity. 
Regarding the taste reactivity test results, the findings of this study are in line 
with previous ones from our laboratory (De Luca et al., 2011a; De Luca et al., 2011b) 
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but also with the general notion that pleasure, sensory hedonia or “liking” is 
independent of DAergic transmission (Berridge & Robinson, 1998; Bassareo et al., 
2002; Di Chiara & Bassareo, 2007). Thus, hedonic reactions were increased in all 
groups to the same extent, independently of the lesion, pre-exposure or increases of 
DA in NAc shell or core. 
Previous studies from this laboratory (Bassareo et al., 2002) have shown that 
adaptive mechanisms (habituation) in NAc shell DA response to highly salient, 
unfamiliar taste stimuli take place in a single-trial mode to both palatable and 
aversive tastes. Regarding the mPFC and the NAc core no single trial habituation is 
observed. Recently, we observed that sensitization to morphine can alter the 
response of different terminal areas of the mesocorticolimbic DA system (De Luca et 
al., 2011a). In the NAc core of rats naive to the taste, morphine sensitization was 
associated to an increased DAergic response to the taste stimulus and to reciprocal 
changes in the adaptive effects of taste pre-exposure on NAc shell and mPFC DA; in 
particular, we observed that morphine sensitization abolished habituation in the NAc 
shell DA and induced it in the mPFC.  In the present study, we also showed that 6-
OHDA lesions of the mPFC can influence the DAergic response of subcortical areas to 
gustatory stimuli and induce changes including the habituation phenomenon. These 
findings are in agreement with the observations of Beyer & Steketee (1999) who 
showed that mPFC 6-OHDA lesions induced sensitization of behavioral and 
neurochemical responses to cocaine. Despite the similarities between the changes 
obtained in our previous and in the current study, the experimental manipulations 
were quite different. The exact mechanisms underlying the induction of these 
phenomena under each condition as well as the neural substrate reflecting the one-
trial habituation under normal conditions remain to be elucidated.   
As already mentioned (see part A, section A.4), mPFC exerts an inhibitory 
influence on the cortical pyramidal projecting neurons (Ferron et al., 1984; Sesack et 
al., 1995) and this might be the mechanism by which it affects the stimulation of DA 
transmission in subcortical areas as NAc induced by drug or by conventional rewards. 
In agreement with this, we observed that ablation of mPFC DA disinhibited NAc core 
DA and abolished the habituation phenomenon in the NAc shell of naive and pre-
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exposed animals respectively. This is in line with the previous studies showing that 6-
OHDA lesions of the mPFC can modify certain aspects of subcortical functioning. 
Thus, it has been shown that these lesions can produce changes in DAergic 
responding of subcortical areas such as that of NAc DA (King et al., 1997; Deutch et 
al., 1990), TH activity (Rosin et al., 1992) and DAergic transmission in NAc induced by 
pharmacological challenges (Banks & Gratton, 1995; Thompson & Moss, 1995; 
Beyer & Steketee, 1999).  
The results of the studies provide evidence of an inhibitory role of cortical DA on 
subcortical DA. To our knowledge only one previous study has investigated the 
changes in DAergic transmission in the NAc induced by natural stimuli in rats 
lesioned by 6-OHDA in the mPFC (Mitchell & Gratton, 1992). However, in this study 
no distinction was made between NAc shell and core. However, King et al. (1997) 
demonstrated that in rats lesioned with 6-OHDA in the mPFC basal levels of DA were 
increased and the stimulatory effect of stress was increased in the NAc shell but not 
in the core. Moreover, mPFC lesions potentiated the increase of DA induced by 
amphetamine in the NAc shell but reduced that in the NAc core. These results 
suggest the existence of differences in the DA responsiveness among the NAc 
compartments after 6-OHDA lesions of the mPFC which might explain the 
discrepancies existing in the literature on the effect of 6-OHDA lesions of the mPFC 
on  DA in the NAc (see section A.4). The present study sheds light on this issue by 
investigating the DAergic responses of NAc shell and core separately. However, 
unlike King and his collegues (1997), we did not observe differences in the basal 
levels of DA in the shell and core of lesioned animals. We observed instead, clearcut 
differences in chocolate-induced increase in DA levels between the shell and core   in 
response to the 1st and to the 2nd exposure to the taste stimulus.  
A further difference between the present study and that of Mitchell and Gratton 
(1992), is the fact that 6-OHDA lesions were unilateral. This “partial” DAergic 
depletion could have particular effects on behavior or DAergic transmission. In fact, 
it has been observed that 6-OHDA lesions of the left brain hemisphere have higher 
impact than those on the right hemisphere, increasing voluntary ethanol 
consumption (Nielsen et al., 1999) and DA utilization in the NAc after footshock 
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(Carlson et al., 1996). In the experiments presented here, rats underwent two 
bilateral microinjections of 6-OHDA which induced a massive DAergic terminal loss 
as shown by the loss of tissue DA and of TH.   
One possible explanation for the present microdialysis results could include as 
already mentioned the disinhibition of the pyramidal projecting neurons to 
subcortical areas. The mPFC sends glutamatergic projections to subcortical areas 
including the NAc and the VTA. Removing the inhibitory effect of DA in the mPFC 
could result in excitation of the projecting neurons to both cell bodies and axon 
terminals in VTA and NAc respectively. Moreover, indirect connections with other 
brain areas as the PPTg which has a direct excitatory connection with the VTA could 
influence the NAc DAergic neurotransmission (for further discussion see also 
Tzschentke, 2001). Further studies are needed in order to clarify the level of 
interaction between cortical and subcortical regions.  
The disruption of the DAergic inhibitory control of the mPFC could potentiate 
stress-induced psychotic symptoms in schizophrenic patients (Weinberger, 1987), 
could lead to increased vulnerability to the addictive effects of drugs (Deminière et 
al., 1989; Piazza et al., 1991) or might result in a general alteration of DAergic 
responses to “pharmacological or environmental challenges of the system” that in 
turn could lead to increased efficacy of conventional or drug reinforcers (McGregor 
et al., 1996). Apart from producing increased responses in NAc core, it was also 
observed that the lesions interfere with the adaptive mechanisms on NAc shell DA, 
thus showing that dopamine in the mPFC plays an important role on these adaptive 
mechanisms. Future studies might reveal certain aspects of behavior more 
prominently affected by the lesions. These might include abnormal motivational 
learning with direct implications in compulsive disorders, substance abuse and binge 
eating. In addition, taking in consideration the important role of mPFC DA in higher 
order cognitive functions as working memory (Sawaguchi & Goldman-Rakic, 1991), 
behavioral flexibility (Bubser & Schmidt, 1990; Lanser et al., 2001) instrumental 
responses (Naneix et al., 2009) and anxiety (Espejo, 1997)(see also section A.3.2) the 
disruptions of DAergic transmission in this area might result in cognitive disturbances 
that could interact with motivational mechanisms and related aspects of behavior. 
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Loss of DA in the mPFC cmight result in an increased response of subcortical DA 
which in turn might abnormally facilitate incentive arousal and learning (De Luca et 
al., 2011a).  
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